Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan-Reference-Cited by-同舟云学术

Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan

Published:2007-10 Issue:10 Volume:82 Page:873-880
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Saito Akiko M.,Kami Masahiro,Mori Shin-Ichiro,Kanda Yoshinobu,Suzuki Ritsuro,Mineishi Shin,Takami Akiyoshi,Taniguchi Shuichi,Takemoto Yoshinobu,Hara Masamichi,Yamaguchi Masaki,Hino Masayuki,Yoshida Takashi,Kim Sung-Won,Hori Akiko,Ohashi Yasuo,Takaue Yoichi

Publisher

Wiley

Subject

Hematology

Reference41 articles.

1. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age

2. Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

3. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

4. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

5. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study;Blood Cancer Journal;2021-07

2. Comparison of valproate and levetiracetam for the prevention of busulfan-induced seizures in hematopoietic stem cell transplantation;International Journal of Hematology;2019-03-26

3. Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis;Journal of Cancer Research and Clinical Oncology;2017-05-03

4. Donor Chimerism Early after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation Predicts Relapse and Survival;Biology of Blood and Marrow Transplantation;2014-10

5. Critical review of ‘Public domain application’: a flexible drug approval system in Japan;Annals of Oncology;2013-05